Should You Use CBD to Help Your Puppy Sleep?


Ryan Allway

January 19th, 2022

News


Cannabidiol, better known as CBD, has become one of the world’s most popular health and wellness supplements for pets. According to Grand View Market Research, nearly a quarter of pet owners consume CBD-based products for themselves or their pets. And CBD could help treat medical conditions, including pain, anxiety, and sleep disorders.

Sleep is a common challenge for pet owners with new puppies. While puppies sleep longer during the day, they sleep far less at night, resulting in less sleep for pet owners. Fortunately, there are some strategies that you can use to help promote sleep (and get a good night’s rest yourself)—including the use of CBD supplements.

Is CBD Safe for Puppies?

CBD is a safe supplement that rarely produces adverse side effects in pets. In fact, the only rare side effects include drowsiness (a benefit for sleep) and slight diarrhea. That said, you should be careful to provide your pet with the correct dosage based on their weight and select products that are thoroughly screened for toxins.

While CBD is almost certainly safe for puppies, that doesn’t mean pet owners should immediately start dosing their puppy with the supplement. Many of the bad behaviors that puppies exhibit (such as biting, chewing, or not sleeping) are simply part of their youth. If they don’t grow out of these behaviors, consult your vet or consider training before dosing CBD.

Does CBD Help Puppies Sleep?

Researchers haven’t conducted controlled studies that specifically look at the effects of CBD on a puppy’s sleep. However, research does show that CBD helps reduce pain and anxiety, among a host of other benefits. These results mean that one can reasonably assume that CBD would help dogs fall asleep easier, particularly with drowsiness as a side effect.

For instance, a University of Western Australia study found that shelter dogs exhibited less aggression toward humans after a 15-day CBD treatment versus placebo. Meanwhile, a Cornell University study found that arthritic dogs receiving CBD showed significant improvement in pain relief and quality of life—even climbing stairs once again.

How to Buy & Administer CBD

There are hundreds of different CBD products on the market, making it hard for pet owners to determine what’s best for their pets. Broad-spectrum products are generally best because they involve cannabinoids and terpenes that interact in the so-called entourage effect. However, you should seek out pet-specific products with no THC.

Most veterinarians recommend about 0.1 to 0.2 milligrams per kilogram of your puppy’s weight, given twice daily by mouth, although it’s a good idea to consult with your veterinarian beforehand. While you may scale up the dosage if you don’t notice any effects, it’s critical to realize that higher dosages don’t necessarily translate to a greater effect.

The Bottom Line

Puppies are notorious for keeping their owners awake at night and CBD supplements can be helpful to improve sleep. That said, you should consult with your veterinarian to determine the best plan of action while keeping in mind that all puppies go through a stage of hyperactivity that they eventually grow out of over time.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading